Literature DB >> 12961086

Apoptosis and antioxidant defense in the nephrotic syndrome.

Jacek Zachwieja1, Waldemar Bobkowski, Marcin Zaniew, Agnieszka Dobrowolska-Zachwieja, Maria Lewandowska-Stachowiak, Aldona Siwińska.   

Abstract

Nephrotic syndrome (NS) is accompanied, and probably caused by, abnormalities in T lymphocyte function. The aim of this study was to investigate the antioxidant status of children with NS and its influence on the apoptosis of T cells. Fifty-seven children with NS were studied, aged 4-16 years (mean 7.4 years), 34 with a first episode (group I) and 23 in remission (>6 months) of NS (group II). The control group comprised 26 healthy children matched for age. Annexin V-FITC was used as a sensitive probe for identifying cells undergoing apoptosis. We found that apoptotic T lymphocytes occurred more frequently in patients with a first episode of NS than in children in remission and in the controls. In group I, total antioxidant status (TAS, plasma) was significantly reduced compared with controls (0.77+/-0.14 vs. 1.18+/-0.42 mmol/l, P<0.001). In group I children, glutathione reductase (GR, red blood cells) and glutathione peroxidase (GPX, red blood cells) activity was lower than in controls (GR 8.10+/-2.40 vs.10.55+/-3.81 U/g Hb, P<0.001) (GPX 28.65+/-6.99 vs. 33.84+/-13.11 U/g Hb, P=0.010). TAS levels and GR activity in group II were also lower than in the controls. A negative correlation between GR activity and the apoptosis rate of T lymphocytes was found. We conclude that in patients with NS, reduced antioxidant defense may contribute to an increase in the apoptosis rate of circulating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12961086     DOI: 10.1007/s00467-003-1250-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Virological and immunological effects of antioxidant treatment in patients with HIV infection.

Authors:  F Müller; A M Svardal; I Nordoy; R K Berge; P Aukrust; S S Frøland
Journal:  Eur J Clin Invest       Date:  2000-10       Impact factor: 4.686

2.  Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.

Authors:  J Stachowski; C Barth; J Michałkiewicz; T Krynicki; T Jarmoliński; D Runowski; M Lewandowska-Stachowiak; M Zaniew; A Warzywoda; E Bortkiewicz; M Dobosz; J Maciejewski; C A Baldamus
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

3.  Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.

Authors:  B Skrzep-Poloczek; A Tomasik; R Tarnawski; L Hyla-Klekot; A Dyduch; C Wojciechowska; W Wesolowski; E Kopieczna-Grzebieniak; J Zalejska-Fiolka; E Widera
Journal:  Nephron       Date:  2001-09       Impact factor: 2.847

4.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

5.  Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.

Authors:  G Mantovani; A Macciò; G Melis; L Mura; E Massa; M C Mudu
Journal:  Int J Cancer       Date:  2000-06-15       Impact factor: 7.396

6.  Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.

Authors:  W Gwinner; U Landmesser; R P Brandes; B Kubat; J Plasger; O Eberhard; K M Koch; C J Olbricht
Journal:  J Am Soc Nephrol       Date:  1997-11       Impact factor: 10.121

7.  Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes.

Authors:  C Haslett
Journal:  Clin Sci (Lond)       Date:  1992-12       Impact factor: 6.124

8.  T-cell subpopulations in childhood nephrotic syndrome.

Authors:  K Kobayashi; N Yoshikawa; H Nakamura
Journal:  Clin Nephrol       Date:  1994-05       Impact factor: 0.975

Review 9.  Role of iron and oxygen radicals in the progression of chronic renal failure.

Authors:  A C Alfrey
Journal:  Am J Kidney Dis       Date:  1994-02       Impact factor: 8.860

Review 10.  The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.

Authors:  J S Levine; J S Koh
Journal:  Semin Nephrol       Date:  1999-01       Impact factor: 5.299

View more
  7 in total

1.  NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome.

Authors:  Amal Al-Eisa; Gursev S Dhaunsi
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

2.  Steroid sparing effect of a herbal preparation in steroid-dependent nephrotic syndrome.

Authors:  Arpana Iyengar; Hrishikesh Damle; Chanda Kulkarni; Latha Damle; Kishore Phadke
Journal:  Pediatr Nephrol       Date:  2006-04-20       Impact factor: 3.714

3.  Antioxidant status of children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Aditya K Gupta; Rajniti Prasad; Ziledar Ali; Ram S Upadhyay; Surendra P Mishra; Narendra K Tiwary; Franz S Schaefer
Journal:  Pediatr Nephrol       Date:  2010-11-21       Impact factor: 3.714

4.  Evaluation of certain constituents of antioxidant defense in youth treated in the past for steroid-sensitive idiopathic nephrotic syndrome.

Authors:  Maria Hanna Kniazewska; Anna Karolina Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Lidia Hyla-Klekot
Journal:  Pediatr Nephrol       Date:  2009-07-28       Impact factor: 3.714

5.  Oxidant stress in primary nephrotic syndrome: does it modulate the response to corticosteroids?

Authors:  Ashraf Bakr; Sami Abul Hassan; Mohamed Shoker; Mayssa Zaki; Rasha Hassan
Journal:  Pediatr Nephrol       Date:  2009-07-31       Impact factor: 3.714

6.  Role of reactive oxygen species in pathogenesis of nephrotic syndrome.

Authors:  Santoshi R Ghodake; A N Suryakar; R D Ankush; K Shaikh; A V Katta
Journal:  Indian J Clin Biochem       Date:  2010-02-10

7.  Role of free radicals and antioxidant status in childhood nephrotic syndrome.

Authors:  S R Ghodake; A N Suryakar; R D Ankush; R V Katkam; K Shaikh; A V Katta
Journal:  Indian J Nephrol       Date:  2011-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.